Abstract #T350
Section: Production, Management and the Environment
Session: Production, Management and the Environment II
Format: Poster
Day/Time: Tuesday 7:30 AM–9:30 AM
Location: Gatlin Ballroom
Session: Production, Management and the Environment II
Format: Poster
Day/Time: Tuesday 7:30 AM–9:30 AM
Location: Gatlin Ballroom
# T350
Influence of growth-promoting implants on endocrine factors and efficiency of replacement beef heifers.
Laura R. Meyer*1, Thomas L. Devine1, Michael L. Looper1, Dirk Philipp1, Donald S. Hubbell2, Rick W. Rorie1, Charles F. Rosenkrans1, 1Department of Animal Science, Division of Agriculture, University of Arkansas, Fayetteville, AR, 2Livestock and Forestry Research Station, Division of Agriculture, University of Arkansas, Batesville, AR.
Key Words: cortisol, IGF-I, prolactin
Influence of growth-promoting implants on endocrine factors and efficiency of replacement beef heifers.
Laura R. Meyer*1, Thomas L. Devine1, Michael L. Looper1, Dirk Philipp1, Donald S. Hubbell2, Rick W. Rorie1, Charles F. Rosenkrans1, 1Department of Animal Science, Division of Agriculture, University of Arkansas, Fayetteville, AR, 2Livestock and Forestry Research Station, Division of Agriculture, University of Arkansas, Batesville, AR.
Anabolic steroid implants are commonly used in the beef industry to increase BW gain in feedyard cattle. However, there are a limited number of implants approved for use in replacement heifers. Objectives were to use growth-promoting implants to add value to low-BW heifers, and to determine the relationships among hormones and cow efficiency. Charolais × Balancer heifers (n = 65; 179 ± 30 kg; 255 ± 12 d of age) were used to determine the influence of androgenic and(or) estrogenic implants on serum concentrations of insulin-like growth factor-I (IGF-I), prolactin (PRL), cortisol (CORT), and reproduction. Heifers were blocked by BW and assigned to 1 of 4 implant treatment groups: 1) control, no implant (CON; n = 16); 2) trenbolone acetate (TBA; 200 mg of TBA; n = 15); 3) trenbolone acetate plus estradiol (TBA+E2; 40 mg TBA and 8 mg E2; n = 17); or 4) zeranol (ZER; 36 mg ZER; n = 17). Heifers were implanted on d 0, and blood samples collected on d 0 (15 Nov), 106 (1 Mar), and 195 (29 May) of the experiment. Heifers were AI on d 220 and exposed to an Angus bull for 28 d starting 12 d after AI. Calf birth date, and birth weight were recorded. At weaning, dam and calf weights were determined and cow efficiency was calculated by dividing calf adjusted 205 d weight by dam weight at weaning. Treatment did not influence (P > 0.10) calving rate (41.5%), Julian calving date (96.8 ± 2.5 d), cow efficiency (0.47 ± 0.23), concentrations of IGF-I (78.4 ± 3.9 ng/mL), PRL (83.5 ± 5.81 ng/mL), CORT (36.3 ± 9.9 ng/mL), or PRL:CORT (ratio = 2.19 ± 0.24). Serum PRL and IGF-I increased (P < 0.01) from d 0 to 195. Serum cortisol increased (P < 0.01) from d 0 to 106, and concentrations were similar from d 106 to 195. Multiple regression analyses indicated PRL and IGF-I at d 195 described 30% of variation in adjusted 205 d calf weights; 35% of variation in cow weight at weaning was explained by PRL at d 0 and 106; and PRL:CORT at d 0 and IGF-I at d 195 accounted for 44% of variation in cow efficiency. Anabolic implants did not affect heifer reproduction. Serum PRL, CORT, and IGF-I of heifers at weaning, yearling, and pre-breeding may serve as biomarkers of cow efficiency.
Key Words: cortisol, IGF-I, prolactin